Actively Recruiting

All Genders
NCT04541654

Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress

Led by Dana-Farber Cancer Institute · Updated on 2026-03-27

1500

Participants Needed

3

Research Sites

641 weeks

Total Duration

On this page

Sponsors

D

Dana-Farber Cancer Institute

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this research study is to learn more about variants in the TP53 gene both associated with Li-Fraumeni Syndrome (LFS), a hereditary cancer risk condition, and TP53 variants found in the blood for other reasons (e.g. ACE/CHIP and mosaicism).

CONDITIONS

Official Title

Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Individuals with a TP53 pathogenic or likely pathogenic variant identified in blood or saliva
  • Individuals with variants of uncertain significance in TP53 may be eligible at the PI's discretion
  • Blood relatives of individuals with a TP53 variant, who may be presumed obligate carriers or healthy controls
  • Individuals who meet Classic or Chompret LFS criteria whether or not they have a TP53 gene variant
  • Individuals may enroll their deceased relatives in the study
  • Individuals with a known TP53 variant that is not LFS, but rather ACE, CHIP, or mosaicism
  • Individuals participating in other LFS studies can still enroll in LiFT UP. Investigators may be collaborators
Not Eligible

You will not qualify if you...

  • Individuals who decline to sign consent
  • Individuals who are unable to give consent or assent and are without a designated healthcare proxy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Boston Children's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

2

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02215

Actively Recruiting

3

Judy E. Garber

Boston, Massachusetts, United States, 02215

Actively Recruiting

Loading map...

Research Team

J

Judy E Garber, MD, MPH

CONTACT

S

Sophie Cahill, BS

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress | DecenTrialz